156 related articles for article (PubMed ID: 10425577)
1. Treatment of metastatic glucagonoma to the liver: case report and literature review.
Casadei R; Tomassetti P; Rossi C; la Donna M; Migliori M; Marrano D
Ital J Gastroenterol Hepatol; 1999 May; 31(4):308-12. PubMed ID: 10425577
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic imaging of glucagonoma and transcatheter arterial embolization in hepatic metastases--report of a case].
Shimizu T; Hirota S; Sako M; Ohtsuki S; Hasegawa M; Hanaguri K; Yamamoto M; Kadowaki S
Rinsho Hoshasen; 1986 Mar; 31(3):433-6. PubMed ID: 3014183
[No Abstract] [Full Text] [Related]
3. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic long-term follow-up of a patient with metastatic glucagonoma.
Lipp RW; Schnedl WJ; Stauber R; Ranner G; Leb G; Krejs GJ
Am J Gastroenterol; 2000 Jul; 95(7):1818-20. PubMed ID: 10925991
[TBL] [Abstract][Full Text] [Related]
5. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
Nesović M; Cirić J; Radojković S; Zarković M; Durović M
J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
[TBL] [Abstract][Full Text] [Related]
6. [Long-time survival case of glucagonoma metastatic to the liver treated with TAE therapy].
Fujimoto M; Ueda Y; Amari M; Moriyama H; Sakurai T; Okano H; Nagata M; Yokono K
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1329-31. PubMed ID: 10465984
[No Abstract] [Full Text] [Related]
7. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Krenning EP; Kooij PP; Bakker WH; Breeman WA; Postema PT; Kwekkeboom DJ; Oei HY; de Jong M; Visser TJ; Reijs AE
Ann N Y Acad Sci; 1994 Sep; 733():496-506. PubMed ID: 7978900
[No Abstract] [Full Text] [Related]
8. Malignant glucagonoma. New options of treatment.
Appetecchia M; Ferretti E; Carducci M; Izzo F; Carpanese L; Marandino F; Terzoli E
J Exp Clin Cancer Res; 2006 Mar; 25(1):135-9. PubMed ID: 16761630
[TBL] [Abstract][Full Text] [Related]
9. [Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma].
D'Alteroche L; Viguier J; Maillard H; Debbabi S; Certin M; Metman EH
Gastroenterol Clin Biol; 2000 Jan; 24(1):132-3. PubMed ID: 10755862
[No Abstract] [Full Text] [Related]
10. [Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
Strohm WD
Z Gastroenterol; 1996 Jul; 34(7):438-45. PubMed ID: 8928539
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
12. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
[TBL] [Abstract][Full Text] [Related]
13. Sonographic features of liver metastases from pancreatic glucagonoma and acinar cell carcinoma. Case reports.
Ferrari A; Gavinelli M; Dominioni L; Carcano G; Dionigi R
Surg Endosc; 1996 Jul; 10(7):762-4. PubMed ID: 8662436
[TBL] [Abstract][Full Text] [Related]
14. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
Bouin M; Aoust LD
Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated liver perfusion with melphalan and bevacizumab.
Voron T; Zinzindohoué F; Journois D; Hervé C; Ponzio O; Lucas N
J Visc Surg; 2013 Feb; 150(1):60-6. PubMed ID: 23182850
[TBL] [Abstract][Full Text] [Related]
16. Glucagonoma syndrome. Rapid response following arterial embolization of glucagonoma metastatic to the liver.
Assaad SN; Carrasco CH; Vassilopoulou-Sellin R; Samaan NA
Am J Med; 1987 Mar; 82(3):533-5. PubMed ID: 3030099
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic glucagonoma presenting as a pulmonary mass.
Pinto Marín A; Hernández Agudo E; Feliú J; González Barón M
Clin Transl Oncol; 2009 Jan; 11(1):60-2. PubMed ID: 19155206
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
19. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
[TBL] [Abstract][Full Text] [Related]
20. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
